Here at HIS Hair, we pride ourselves on being the world’s leading practitioners in Scalp Micropigmentation treatment – a non-surgical treatment spread over several sessions which includes the insertion of specially designed pigments to create the illusion of a full head of hair. However, we also like to take a day off from sharing our magic to raise awareness of the many ways to combat our common enemies. In this case – Alopecia Areata.
The Common Enemy
Alopecia Areata is an autoimmune disease – a disease that occurs when your own immune system mistakes healthy cells for dangerous ones and proceeds to damage them. With Alopecia Areata, the protective white blood cells gather around the affected hair roots – which they mistake as foreign – and begin to attack and damage them causing inflammation, weakness, and subsequently the falling out of them.
Alopecia Areata affects 15 in every 10,000 people in the UK alone – that’s 6,410 people – as one of the leading types of Alopecia – the most common form of hair loss. Alopecia Areata often becomes active before the age of twenty-one in mild forms before becoming considerably more severe with age.
The Search for a Cure
As technology develops, so does the search for a cure to this increasingly common disease. The most recent discovery has been the promising rise in phototherapy with ultraviolet A-1.
A research letter published in the October 2015 issue of the International Journal of Dermatology reveals that phototherapy via ultraviolet A-1 has the potential to improve the effects of Alopecia Areata considerably – with the wider possibility of maintaining it for a particular amount of months following the end of treatment.
Dr Maira E. Herz-Ruelas from the University Hospital in Monterrey, Mexico, treated four patients with refractory Alopecia Areata with UVA-1 phototherapy – the exposure of the skin to specific wavelengths of light or electromagnetic radiation. Before and after each of the 75 sessions, Dr Herz-Ruelas and her team obtained two 4mm scalp biopsies from the margin of an alopecic plague.
The research confirmed what Dr Herz-Ruelas set out to confirm – that phototherapy would reduce the various levels that Alopecia Areata unfortunately heightens. The results of the sessions revealed a prominent reduction on inflamed follicles, a reduction in hair follicle miniaturisation, and a significant increase in anagen hairs and a considerable absence of telogen remnants. These improvements were sustained for six months after the end of the treatment.
Dr Herz-Ruelas believes that the research has highlighted UVA-1 as a potential candidate to be included as a therapeutic alternative for patients unresponsive to previous pharmacological treatments.
If you’re currently suffering from Alopecia Areata – or know someone who is – and aren’t too keen on waiting around for access to this therapeutic treatment, then we here at HIS have got your back. Our SMP treatment is available in 17 clinics in 4 different continents, with over 100 different shades of pigments to match your unique colourings.
Alopecia Areata is one of the most common forms of Alopecia, and of hair loss in general, and is often the cause of hundreds of confidence crashes year in and year out – call us today, book a consultation, and get yourself back on your feet. To find your nearest clinic click here